Inactive Instrument

Labomar S.p.A.

LBM

IT0005421646

Labomar S p A : REACHES 100% OWNERSHIP OF LABIOTRE

November 24, 2021 at 06:30 am EST

Labiotre will join the Labomar Group consolidation scope on December 1, 2021. Walter Bertin, founder and CEO of Labomar stated: "Top raw material quality is key to the provision of excellent products - and even more particularly in the nutraceutical sector. Full control of Labiotre, with a view to controlling the supply chain and the complete monitoring of the value chain allows us to make successful, cutting-edge products."

Attachments

Original Link
Original Document
Permalink

Disclaimer

Labomar S.p.A. published this content on 23 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 November 2021 11:29:16 UTC.

Latest news about Labomar S.p.A.

Labomar obtains B CORP certification together with Importfab and Welcare	23-09-19	AN
First Capital exits Labomar and cashes in EUR9 million	23-08-07	AN
LBM Next S.P.A. made a bid to acquire 4.9% stake in Labomar S.p.A. from First Capital S.p.A. for ?9 million.	23-08-06	CI
Europe opens flat; Recordati does well on Mib.	23-07-21	AN
Labomar's revenues grow by double digits in the first half of the year	23-07-20	AN
Mib up slightly, caution reigns in markets	23-07-20	AN
Weak start expected for European indexes	23-07-20	AN
Mib keeps afloat; Nexi closes as best	23-07-19	AN
Labomar board assesses congruous value of LBM Next's takeover bid	23-07-04	AN
Mib in red recovers and goes to 27,000 mark	23-06-26	AN
Milan black jersey; bankers suffer on Mib.	23-06-26	AN
Milan black jersey; bankers suffer on Mib.	23-06-26	AN
Labomar, condition precedent for LBM takeover bid comes true	23-06-23	AN
Futures weak ahead of PMIs; eyes on Juve	23-05-23	AN
Milan just above 27,300; luxury does well	23-05-22	AN
ITALY GROWTH WINNERS & LOSERS: Labomar rises after takeover announcement	23-05-22	AN
LBM-Charterhouse launch takeover bid on Labomar; stock nears offer	23-05-22	AN
Charterhouse Capital Partners LLP agreed to acquire 32% stake in Labomar S.p.A. for â‚¬10 per share	23-05-21	CI
Labomar, first quarter revenues at EUR28 million approx.	23-04-20	AN
Stock markets sluggish; Saipem advances after accounts	23-04-20	AN
Milan up; Chinese bank does not touch rates	23-04-20	AN
Milan rises above 27,900; MPS bullish	23-04-19	AN
Stock exchanges still bullish in wake of Wall Street	23-03-30	AN
Milan best in Europe; stock markets rebound	23-03-29	AN
Labomar, profit drops in 2022 but revenue and Ebitda grow	23-03-29	AN

Chart Labomar S.p.A.

Duration

Period

More charts

Company Profile

LABOMAR S.R.L. is an Italy-based company, which produces dietary supplements, in either solid format or as liquids. The Company's oral solid products include chewable tablets, swallable tablets, coated tablets, gastro-resistant tablets, time release tablets, micro tablets, hard plant or animal gelatine capsules, oro dispersible powders, and water dispersible powders. Its oral liquid products include syrups, hydroglyceric and hydroalcoholic suspensions, solutions, emulsions, and nanoemulsions. The Company serves companies operating in the medical information sector, in distribution channels in chemist and herbalists shops, retail stores of products for athletes and retail organization.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+51.54%	795B
NOVO NORDISK A/S	+41.27%	627B
JOHNSON & JOHNSON	-7.20%	350B
MERCK & CO., INC.	+18.67%	328B
ABBVIE INC.	+7.48%	294B
ASTRAZENECA PLC	+17.79%	245B
ROCHE HOLDING AG	+1.27%	222B
NOVARTIS AG	+11.82%	215B
AMGEN INC.	+3.64%	160B

Other Pharmaceuticals